Four copper(II) compounds synthesized by anion regulation: Structure, anticancer function and anticancer mechanism

Eur J Med Chem. 2016 Oct 4:121:399-409. doi: 10.1016/j.ejmech.2016.05.021. Epub 2016 May 14.

Abstract

Copper (Cu) compounds are a promising candidate for next generation metal anticancer drugs. Therefore, we regulated anions to synthesize four mononuclear and binuclear Cu(II) compounds derived from thiosemicarbazone Schiff base ligands and characterized them. Four of these compounds showed very high cytotoxicity to cancer cell lines in vitro. These Cu(II) compounds strongly promoted the apoptosis of BEL-7404 cells and had a capacity to arrest the cell cycle at S phase of those cells. Furthermore, reactive oxygen species (ROS), mitochondrial membrane potential and Western blot analyses revealed that these Cu(II) compounds exert their cytotoxicity through an ROS-mediated intrinsic mitochondrial pathway accompanied by the regulation of Bcl-2 family proteins.

Keywords: Bcl-2 family proteins; Copper compound; Mitochondrial membrane potential; Reactive oxygen species; Thiosemicarbazone Schiff base ligands.

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Cell Cycle / drug effects
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Chemistry Techniques, Synthetic
  • Copper / chemistry*
  • Humans
  • Membrane Potential, Mitochondrial / drug effects
  • Models, Molecular
  • Molecular Conformation
  • Organometallic Compounds / chemical synthesis*
  • Organometallic Compounds / chemistry
  • Organometallic Compounds / pharmacology*
  • Reactive Oxygen Species / metabolism
  • Thiosemicarbazones / chemistry

Substances

  • Antineoplastic Agents
  • Organometallic Compounds
  • Reactive Oxygen Species
  • Thiosemicarbazones
  • Copper